Search results for "OUTCOME"

showing 10 items of 5148 documents

Epidemiological Study of Tricuspid Regurgitation After Cardiac Transplantation. Does it Influence Survival?

2022

Background: Tricuspid valve disease is the most frequent valvulopathy after heart transplantation (HTx). Evidence for the negative effect of post-transplant tricuspid regurgitation (TR) on survival is contradictory. The aim of this study was to analyze the causes of post-transplant TR and its effect on overall mortality.Methods: This is a retrospective observational study of all transplants performed in two Spanish centers (1009 patients) between 2000 and 2019. Of the total number of patients, 809 had no TR or mild TR and 200 had moderate or severe TR. The etiology of TR was analyzed in all cases.Results: The prevalence of moderate and severe TR was 19.8%. The risk of mortality was greater …

TransplantationSurvivalIncidenceTricuspid regurgitationHeart transplantationPrognosisSeverity of Illness IndexTricuspid Valve Insufficiency*aetiologyTreatment Outcome*heart transplantation*tricuspid regurgitation*prognosisHumansHeart Transplantation*survivalAetiologyRetrospective StudiesTransplant international : official journal of the European Society for Organ Transplantation
researchProduct

[The role of the anesthesiologist in secondary hyperparathyroidism].

2010

In the last years the increasing of diabetes and hypertension has produced a considerable increase of patients with chronic renal failure; secondary hyperparathyroidism is one of the major complications. The resection of hyperfunctioning parathyroid tissue is the ultimate goal of the treatment. The preoperative examination by the anesthetist is the starting-point of the treatment. The anesthetist programs hemodialysis, the correction of fluid and electrolyte abnormalities and of the anaemia. In the operating room the anesthetist is involved in the careful monitoring of liquid infusion and anesthesiological procedure. The intraoperative parathyroid hormone (PTH) assay is an essential tool be…

Treatment OutcomeAnesthesiologyParathyroid HormoneRenal DialysisMonitoring IntraoperativeSettore MED/41 - AnestesiologiaHumansKidney Failure ChronicHyperparathyroidism Secondaryhyperparathyroidism calciumPhysician's RoleBiomarkersIl Giornale di chirurgia
researchProduct

[Non-invasive trans-cranial magnetic resonance imaging-guided focused ultrasounds surgery to treat neurologic disorders]

2016

Negli anni passati le applicazioni non invasive degli ultrasuoni focalizzati guidati da risonanza magnetica per il trattamento dei disordini neurologici sono state osta- colate da limiti tecnici oggi finalmente superati. In Italia, nel corso del 2015, sono stati effettuati i primi trattamenti utilizzando per la prima volta al mondo un comune scanner di risonanza magnetica da 1.5T. I risultati a oggi ottenuti con questa nuova metodica e le sue future possibili appli- cazioni sono molto promettenti e aprono la strada verso nuove opzioni terapeutiche, sicure ed efficaci, un tempo impensabili. In past years non-invasive clinical applications of magnetic resonance-guided focused ultrasound for t…

Treatment OutcomeItalySettore MED/27 - NeurochirurgiaHumansHigh-Intensity Focused Ultrasound AblationSettore MED/37 - NeuroradiologiaNervous System DiseasesMagnetic Resonance ImagingHuman
researchProduct

Hydrogels in maxillofacial prosthesis

2017

Background: There is a growing need for prosthetic replacements in humans due to various reasons. Oro-facial deformities contribute more for these treatment modalities due to impairment in both function and esthetics. Biomaterials play an important role in replacing any form of defects. Selection of a good biomaterial is of prime importance as these materials determine the success of the treatment outcome. Acrylic resins and silicones are the most popular materials for replacing the lost tissues as far as the maxillofacial prosthesis is concerned. But these materials only help in covering the defect and give a very little therapeutic effect. Acrylic resins are very rigid materials and are l…

Treatment modalitybusiness.industryBiological propertyTreatment outcomeSelf-healing hydrogelstechnology industry and agricultureBiomaterialMaxillofacial ProsthesisMedicineDentistrybusinessBiocompatible materialEdge strengthIndian Journal of Multidisciplinary Dentistry
researchProduct

A multicentre randomized controlled trial on trans-generational attention deficit/hyperactivity disorder (ADHD) in mothers and children (AIMAC): an e…

2018

Abstract. Objective: We examined predictors and moderators of treatment outcome in mothers and children diagnosed with ADHD in a large multicentre RCT. Method: In total, 144 mother-child dyads with ADHD were randomly assigned to either a maternal ADHD treatment (group psychotherapy and open methylphenidate medication, TG) or to a control treatment (individual counselling without psycho- or pharmacotherapy, CG). After maternal ADHD treatment, parent-child training (PCT) for all mother-child dyads was added. The final analysis set was based on 123 dyads with completed primary outcome assessments (TG: n = 67, CG: n = 56). The primary outcome was the change in each child’s externalizing sympto…

Treatment outcomeMotherslaw.inventionTrans generationalRandomized controlled trialChild of Impaired Parentslawmental disordersmedicineAttention deficit hyperactivity disorderHumans0501 psychology and cognitive sciencesChildbusiness.industry05 social sciencesGeneral MedicineExploratory analysismedicine.diseaseModerationPrognosis3. Good healthPsychiatry and Mental healthClinical PsychologyTreatment OutcomeAttention Deficit Disorder with HyperactivityPediatrics Perinatology and Child HealthMethylphenidatePsychotherapy GroupFemalebusiness050104 developmental & child psychologyClinical psychologyZeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie
researchProduct

Twenty-year trends in the prevalence of Down syndrome and other trisomies in Europe : impact of maternal age and prenatal screening

2013

This study examines trends and geographical differences in total and live birth prevalence of trisomies 21, 18 and 13 with regard to increasing maternal age and prenatal diagnosis in Europe. Twenty-one population-based EUROCAT registries covering 6.1 million births between 1990 and 2009 participated. Trisomy cases included live births, fetal deaths from 20 weeks gestational age and terminations of pregnancy for fetal anomaly. We present correction to 20 weeks gestational age (ie, correcting early terminations for the probability of fetal survival to 20 weeks) to allow for artefactual screening-related differences in total prevalence. Poisson regression was used. The proportion of births in …

TrisomyAbortionPregnancyPrenatal DiagnosisDown Syndrome/diagnosisMedicinetrisomy 18Registriestrisomy 13Genetics (clinical)Geneticseducation.field_of_studyObstetricsPregnancy OutcomeDown syndrome -- Case studiesGestational ageEuropetrisomy 21Fetal Death/epidemiologyFemaleLive birthLive BirthMaternal AgetrendsAdultmedicine.medical_specialtyDown syndromeMedical screeningPopulationPrenatal diagnosisArticlePregnancy Outcome/epidemiologyEurope/epidemiologyAge DistributionGeneticsHumanseducationFetal DeathMaternal agePregnancyChromosomes Human Pair 13business.industryAbortion Inducedmedicine.diseaseTrisomy/diagnosisLive Birth/epidemiologyprenatal screeningTrisomy -- Patients -- CareDown SyndromebusinessTrisomyChromosomes Human Pair 18Abortion Induced/statistics & numerical data
researchProduct

Tumor-infiltrating lymphocytes and breast cancer: Beyond the prognostic and predictive utility

2017

The importance of the immune system as a potent anti-tumor defense has been consolidated in recent times, and novel immune-related therapies are today demonstrating a strong clinical benefit in the setting of several solid neoplasms. Tumor-infiltrating lymphocytes reflect the attempt of the host to eradicate malignancies, and during the last decades, they have been shown to possess an interesting prognostic utility for breast cancer, especially in case of HER2 positive and triple-negative molecular subtypes. In parallel, the clinical evaluation of tumor-infiltrating lymphocytes has been shown to effectively predict treatment outcomes in both neoadjuvant and adjuvant settings. Currently, tu…

Tumor-infiltrating lymphocytes; breast cancer; cancer immunotherapy0301 basic medicineOncologyCA15-3medicine.medical_specialtymedicine.medical_treatmentCA 15-3Tumor-infiltrating lymphocyteBreast NeoplasmsTumor-infiltrating lymphocytes03 medical and health sciencesLymphocytes Tumor-Infiltratingbreast cancer0302 clinical medicineImmune systemBreast cancerCancer immunotherapyInternal medicinemedicineHumansRC254-282cancer immunotherapyTumor-infiltrating lymphocytesbusiness.industryNeoplasms. Tumors. Oncology. Including cancer and carcinogensCancerGeneral MedicinePrognosismedicine.diseaseNeoadjuvant TherapyTreatment Outcome030104 developmental biologyImmunoediting030220 oncology & carcinogenesisFemalebusinessTumor Biology
researchProduct

EPATOBLASTOMI (EPB): UN SUCCESSO DELLA RIUCERCA CLINICA

1994

Dalla revisione della casistica del gruppo di Studio Italiano sui Tumori epatici del Bambino (GSTEB), risulta un miglioramento dell'Outcome di questi pazienti. Gli Autori presentano i risultati dello Studio.

Tumori del bambino0 epatoblastomi. OutcomeSettore MED/38 - Pediatria Generale E SpecialisticaSettore MED/20 - Chirurgia Pediatrica E Infantile
researchProduct

Pyoderma gangrenosum, acne, hidradenitis suppurativa syndrome associated with type 1 diabetes mellitus treated with adalimumab

2019

Type 1 diabetesmedicine.medical_specialtybusiness.industryTreatment outcomeMEDLINEDermatologymedicine.diseaseDermatologyDiabetes mellitusmedicineAdalimumabHidradenitis suppurativaPyoderma gangrenosum acne hidradenitis suppurativabusinessPyoderma gangrenosumAcnemedicine.drug
researchProduct

Predictors of early dropout in treatment for gambling disorder: The role of personality disorders and clinical syndromes

2017

Several treatment options for gambling disorder (GD) have been tested in recent years; however dropout levels still remain high. This study aims to evaluate whether the presence of psychiatric comorbidities predicts treatment outcome according to Millon's evolutionary theory, following a six-month therapy for GD. The role of severity, duration of the disorder, typology of gambling (mainly online or offline) and pharmacological treatment were also analysed. The recruitment included 194 pathological gamblers (PGs) to be compared with 78 healthy controls (HCs). Psychological assessment included the South Oaks Gambling Screen and the Millon Clinical Multiaxial Inventory-III. The "treatment fail…

TypologyAdultMalemedicine.medical_specialtyPatient DropoutsAdolescentSubstance-Related Disorders030508 substance abuseComorbidityPersonality DisordersStress Disorders Post-Traumatic03 medical and health sciencesYoung Adult0302 clinical medicineSettore M-PSI/08 - Psicologia ClinicamedicineSettore MED/48 -Scienze Infermierist. e Tecn. Neuro-Psichiatriche e Riabilitat.HumansPsychological testingTreatment FailurePsychiatryPathologicalSettore MED/25 - PsichiatriaBiological PsychiatryDropout (neural networks)AgedAntisocial personality disorderAntisocial Personality DisorderSyndromeMiddle Agedmedicine.diseasePersonality disorders030227 psychiatryPsychotherapyPsychiatry and Mental healthPassive-Aggressive Personality DisorderCase-Control StudiesGamblingGambling disorderFemale0305 other medical sciencePsychologyGambling disorder Dropout Treatment outcome Personality disorders Clinical syndromes Psychiatric disorders Disordered gambling Pathological gamblingClinical psychology
researchProduct